{"id":31463,"date":"2025-03-25T11:25:47","date_gmt":"2025-03-25T03:25:47","guid":{"rendered":"https:\/\/www.1ai.net\/?p=31463"},"modified":"2025-03-25T11:25:47","modified_gmt":"2025-03-25T03:25:47","slug":"%e6%97%a5%e6%9c%ac%e5%9b%bd%e7%ab%8b%e7%99%8c%e7%97%87%e7%a0%94%e7%a9%b6%e4%b8%ad%e5%bf%83%ef%bc%9aai-%e5%8f%af%e5%a4%a7%e5%b9%85%e6%8f%90%e9%ab%98%e4%b8%b4%e5%ba%8a%e6%8a%a5%e5%91%8a%e6%92%b0","status":"publish","type":"post","link":"https:\/\/www.1ai.net\/en\/31463.html","title":{"rendered":"National Cancer Research Center of Japan: AI can dramatically improve the efficiency of clinical report writing"},"content":{"rendered":"<p>March 24 - Kyodo News reported.<a href=\"https:\/\/www.1ai.net\/en\/tag\/%e6%97%a5%e6%9c%ac\" title=\"_Other Organiser\" target=\"_blank\" >Japan<\/a>Research published today by the National Cancer Institute says that using generative formulas when writing draft reports for clinical trials of new drugs <a href=\"https:\/\/www.1ai.net\/en\/tag\/ai\" title=\"[View articles tagged with [AI]]\" target=\"_blank\" >AI<\/a> The time required could be significantly reduced. Of the 119 drafts produced.<strong>Eighty percent of them can be finalized with only minor revisions by hand.<\/strong>. The center said that by improving the efficiency of the procedures, it could shorten the time it takes for a drug to be approved for use in patients.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-31464\" title=\"7b3a16daj00stnthc002cd000sg00iip\" src=\"https:\/\/www.1ai.net\/wp-content\/uploads\/2025\/03\/7b3a16daj00stnthc002cd000sg00iip.jpg\" alt=\"7b3a16daj00stnthc002cd000sg00iip\" width=\"1024\" height=\"666\" \/><\/p>\n<p>Kenichi Nakamura, head of the international development department at the center's Central Hospital, said the AI could also be used to produce for patients enrolled in the trial<strong>Easy-to-understand explanatory documents<\/strong>Before that, the production of reports was outsourced to professional writers. Previously, the production of reports, for example, had to be outsourced to professional writers, and the process from solicitation to submission to pharmaceutical companies and regulatory authorities required<strong>half a year<\/strong>time, each copy costing as much as<strong>About 5 million yen<\/strong>(Note: The current exchange rate is approximately RMB 243,000).<\/p>\n<p>Japan's National Cancer Research Center and Rozetta, a Tokyo-based company engaged in AI translation, reportedly developed an AI software that inputs the<strong>Clinical trial proposal and data analysis results after the<\/strong>The automatic generation of chapters and writing of reports is also reduced in time to<strong>few days<\/strong>The results of the completion assessment showed that 50 per cent were \"almost ready to use\" and 30 per cent were \"fine-tuned to use\". The results of the completion assessment showed that 50 per cent were \"almost ready for use\" and 30 per cent were \"ready for use after fine-tuning\".<\/p>","protected":false},"excerpt":{"rendered":"<p>March 24 (Bloomberg) -- The use of generative AI in writing drafts of clinical trial reports for new drugs has dramatically reduced the time required, according to research published today by Japan's National Cancer Research Center, Kyodo News reported. Of the 119 drafts written, 80% were finalized with only minor revisions by a human. According to the center, by improving the efficiency of the process, the time it takes for a drug to be approved for use in patients can be shortened. Kenichi Nakamura, head of the international development department at the center's Central Hospital, said AI can also be used to create explanatory documents that are easy to understand for patients participating in trials. Previously, the production of reports and other work was outsourced to professional writers, and it took half a year from the time of bidding to the time of submitting them to pharmaceutical companies and regulators, at a cost of about 5 million yen per copy (note: the current exchange rate is about 24 percent).<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[146],"tags":[411,6064,226],"collection":[],"class_list":["post-31463","post","type-post","status-publish","format-standard","hentry","category-news","tag-ai","tag-6064","tag-226"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/31463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/comments?post=31463"}],"version-history":[{"count":0,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/posts\/31463\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/media?parent=31463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/categories?post=31463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/tags?post=31463"},{"taxonomy":"collection","embeddable":true,"href":"https:\/\/www.1ai.net\/en\/wp-json\/wp\/v2\/collection?post=31463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}